- Filed
- May 19, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 19, 2025 | 89.94M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $4.13M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $29.3M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $26.09M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $5.53M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $4.24M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $4.05M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $6.72M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $120.79M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $121.67M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $175.5M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $171.7M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $192.72M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $182.15M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $143.16M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $141.4M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $311.46M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $302.22M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 90.12M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $7.9M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $7.45M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.11 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.11 |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $2.82M |
| Net Income | Q1 2025 · Mar 31, 2024 | $9.84M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $10.26M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $18.78M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $40.04M |
| Revenue | Q1 2025 · Mar 31, 2024 | $58.82M |